Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Yung

Showing results (311-320 of 345) with videos related to

Pageof 35
Sort By:
Early Intervention in Psychiatry|June 30, 2021
Cannabidiol for at risk for psychosis youth: A randomized controlled trialG Paul Amminger, Ashleigh Lin, Melissa Kerr, et al.
NPJ Schizophrenia|June 27, 2018
NEURAPRO: a multi-centre RCT of omega-3 polyunsaturated fatty acids versus placebo in young people at ultra-high risk of psychotic disorders-medium-term follow-up and clinical courseB Nelson, G P Amminger, H P Yuen, et al.
Biorxiv : the Preprint Server for Biology|February 7, 2023
Systematically characterizing the roles of E3-ligase family members in inflammatory responses with massively parallel Perturb-seqKathryn Geiger-Schuller, Basak Eraslan, Olena Kuksenko, et al.
Schizophrenia Bulletin Open|August 15, 2024
Distress Related to Attenuated Psychotic Symptoms: Static and Dynamic Association With Transition to Psychosis, Nonremission, and Transdiagnostic Symptomatology in Clinical High-Risk Patients in an International Intervention TrialBarnaby Nelson, Hok Pan Yuen, G Paul Amminger, et al.
Biological Psychiatry|June 24, 2023
The Addition of Fish Oil to Cognitive Behavioral Case Management for Youth Depression: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical TrialG Paul Amminger, Simon Rice, Christopher G Davey, et al.
Journal of Psychopharmacology (Oxford, England)|December 13, 2019
Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for PsychopharmacologyThomas Re Barnes, Richard Drake, Carol Paton, et al.
Schizophrenia Research|December 24, 2019
Basic symptoms in young people at ultra-high risk of psychosis: Association with clinical characteristics and outcomesS Youn, L J Phillips, G P Amminger, et al.
Early Intervention in Psychiatry|July 30, 2013
Transitions Study of predictors of illness progression in young people with mental ill health: study methodologyR Purcell, A F Jorm, I B Hickie, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|September 15, 2023
Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and managementMichael Berk, Ole Köhler-Forsberg, Megan Turner, et al.
Schizophrenia Research|December 13, 2018
Dynamic prediction of transition to psychosis using joint modellingH P Yuen, A Mackinnon, J Hartmann, et al.
Pageof 35

Showing results (311-320 of 345) with videos related to

Sort By:
Pageof 35
Early Intervention in Psychiatry|June 30, 2021
Cannabidiol for at risk for psychosis youth: A randomized controlled trialG Paul Amminger, Ashleigh Lin, Melissa Kerr, et al.
NPJ Schizophrenia|June 27, 2018
NEURAPRO: a multi-centre RCT of omega-3 polyunsaturated fatty acids versus placebo in young people at ultra-high risk of psychotic disorders-medium-term follow-up and clinical courseB Nelson, G P Amminger, H P Yuen, et al.
Biorxiv : the Preprint Server for Biology|February 7, 2023
Systematically characterizing the roles of E3-ligase family members in inflammatory responses with massively parallel Perturb-seqKathryn Geiger-Schuller, Basak Eraslan, Olena Kuksenko, et al.
Schizophrenia Bulletin Open|August 15, 2024
Distress Related to Attenuated Psychotic Symptoms: Static and Dynamic Association With Transition to Psychosis, Nonremission, and Transdiagnostic Symptomatology in Clinical High-Risk Patients in an International Intervention TrialBarnaby Nelson, Hok Pan Yuen, G Paul Amminger, et al.
Biological Psychiatry|June 24, 2023
The Addition of Fish Oil to Cognitive Behavioral Case Management for Youth Depression: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical TrialG Paul Amminger, Simon Rice, Christopher G Davey, et al.
Journal of Psychopharmacology (Oxford, England)|December 13, 2019
Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for PsychopharmacologyThomas Re Barnes, Richard Drake, Carol Paton, et al.
Schizophrenia Research|December 24, 2019
Basic symptoms in young people at ultra-high risk of psychosis: Association with clinical characteristics and outcomesS Youn, L J Phillips, G P Amminger, et al.
Early Intervention in Psychiatry|July 30, 2013
Transitions Study of predictors of illness progression in young people with mental ill health: study methodologyR Purcell, A F Jorm, I B Hickie, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|September 15, 2023
Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and managementMichael Berk, Ole Köhler-Forsberg, Megan Turner, et al.
Schizophrenia Research|December 13, 2018
Dynamic prediction of transition to psychosis using joint modellingH P Yuen, A Mackinnon, J Hartmann, et al.
Pageof 35